Visit us at Booth 1076A to discuss:
- Early-phase oncology development
- Global clinical trial strategy
- Enrolment challenges and solutions
- ADC, bispecific, and combination therapy programs
- Regulatory and operational planning
Meet Emerald Clinical’s Oncology Experts at ESMO Madrid 2026, October 23-27, Booth 1076A
Book a Meeting with Us
Why Oncology Sponsors Partner with Emerald Clinical
China Market Leadership
Exceptional access to high-quality sites and large patient pools across China.
Recognized for rapid study start-up, accelerated enrollment, and strong China regulatory strategy capabilities. Access to 1,200+ sites and 70k + patients in China.
Global Development. Local Execution.
Design and execute oncology studies aligned with FHA and EMA strategies while leveraging complementary patient populations and world-class research sites across key global regions.
Expertise in Next-Generation Therapies
Our oncology teams have experience supporting complex development programs across:
- Antibody-drug conjugates (ADCs)
- Bispecific antibodies
- Immuno-oncology therapies
- Combination treatment strategies
- Early-phase and proof-of-concept studies
Smarter Enrollment Strategies
Using predictive enrollment modeling and regional feasibility insights, we help sponsors improve recruitment performance and reduce timeline uncertainty.
Innovative Trial Design
From adaptive designs to modern dose-optimization approaches, we support efficient decision-making throughout development.
Looking for a CRO partner with the scientific expertise, operational agility, and global reach to support your oncology program?
Meet Our Oncology Leaders at ESMO
Connect with Emerald Clinical’s experts during ESMO in Madrid:
